Publications | PubMed=1103999; DOI=10.1007/BF01634146 Schwenk H.-U., Schneider U. Cell cycle dependency of a T-cell marker on lymphoblasts. Blut 31:299-306(1975) PubMed=1086134 Kaplan J., Peterson W.D. Jr. Detection of T-cell lymphoma-associated antigens on cord blood lymphocytes and phytohemagglutinin-stimulated blasts. Cancer Res. 36:3471-3475(1976) PubMed=68013; DOI=10.1002/ijc.2910190505 Schneider U., Schwenk H.-U., Bornkamm G.-W. Characterization of EBV-genome negative 'null' and 'T' cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int. J. Cancer 19:621-626(1977) PubMed=204546; DOI=10.1007/978-3-642-66639-1_32 Schneider U., Schwenk H.-U. Characterization of 'T' and 'non-T' cell lines established from children with acute lymphoblastic leukemia and non-Hodgkin lymphoma after leukemic transformation. Haematol. Blood Transfus. 20:265-269(1977) PubMed=2985879; DOI=10.1016/0145-2126(85)90084-0 Drexler H.G., Gaedicke G., Minowada J. Isoenzyme studies in human leukemia-lymphoma cell lines -- 1 carboxylic esterase. Leuk. Res. 9:209-229(1985) PubMed=3159941; DOI=10.1016/0145-2126(85)90134-1 Drexler H.G., Gaedicke G., Minowada J. Isoenzyme studies in human leukemia-lymphoma cell lines -- III Beta-hexosaminidase (E.C. 3.2.1.30). Leuk. Res. 9:549-559(1985) PubMed=3874327; DOI=10.1016/0145-2126(85)90133-x Drexler H.G., Gaedicke G., Minowada J. Isoenzyme studies in human leukemia-lymphoma cells lines -- II. Acid phosphatase. Leuk. Res. 9:537-548(1985) PubMed=3165345 LaGree K.A., Lee A.T., Stetten G., Strauss P.R. The human Jurkat (FHCRC-11) cell line is heterogeneous in ploidy and cell size and releases detergent-soluble DNA. Exp. Hematol. 16:686-690(1988) PubMed=2144611; DOI=10.1128/mcb.10.10.5502-5509.1990 Cheng J., Haas M. Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines. Mol. Cell. Biol. 10:5502-5509(1990) PubMed=1915666; DOI=10.1016/0014-4827(91)90482-A Limouse M., Manie S., Konstantinova I., Ferrua B., Schaffar L. Inhibition of phorbol ester-induced cell activation in microgravity. Exp. Cell Res. 197:82-86(1991) PubMed=8127147 Heyman M., Grander D., Brondum-Nielsen K., Cederblad B., Liu Y., Xu B., Einhorn S. Interferon system defects in malignant T-cells. Leukemia 8:425-434(1994) PubMed=8547074; DOI=10.1111/j.1365-2141.1995.tb05302.x Siebert R., Willers C.P., Schramm A., Fossa A., Dresen I.M.G., Uppenkamp M., Nowrousian M.R., Seeber S., Opalka B. Homozygous loss of the MTS1/p16 and MTS2/p15 genes in lymphoma and lymphoblastic leukaemia cell lines. Br. J. Haematol. 91:350-354(1995) PubMed=8558913 Morita S., Tsuchiya S., Fujie H., Itano M., Ohashi Y., Minegishi M., Imaizumi M., Endo M., Takano N., Konno T. Cell surface c-kit receptors in human leukemia cell lines and pediatric leukemia: selective preservation of c-kit expression on megakaryoblastic cell lines during adaptation to in vitro culture. Leukemia 10:102-105(1996) PubMed=8641406; DOI=10.1111/j.1600-0609.1996.tb00721.x Borgonovo-Brandter L., Heyman M., Rasool O., Liu Y., Grander D., Einhorn S. p16INK4/p15INK4B gene inactivation is a frequent event in malignant T-cell lines. Eur. J. Haematol. 56:313-318(1996) PubMed=8957066; DOI=10.1111/j.1349-7006.1996.tb03112.x Kawasaki N., Matsuo Y., Yoshino T., Yanai H., Oka T., Teramoto N., Liu C., Kondo E., Minowada J., Akagi T. Metastatic potential of lymphoma/leukemia cell lines in SCID mice is closely related to expression of CD44. Jpn. J. Cancer Res. 87:1070-1077(1996) PubMed=9510473; DOI=10.1111/j.1349-7006.1998.tb00476.x Hosoya N., Hangaishi A., Ogawa S., Miyagawa K., Mitani K., Yazaki Y., Hirai H. Frameshift mutations of the hMSH6 gene in human leukemia cell lines. Jpn. J. Cancer Res. 89:33-39(1998) PubMed=9583678; DOI=10.1038/sj.onc.1201704 Brimmell M., Mendiola R., Mangion J., Packham G. BAX frameshift mutations in cell lines derived from human haemopoietic malignancies are associated with resistance to apoptosis and microsatellite instability. Oncogene 16:1803-1812(1998) PubMed=9685479; DOI=10.1093/nar/26.16.3651 Hultdin M., Gronlund E., Norrback K.-F., Eriksson-Lindstrom E., Just T., Roos G. Telomere analysis by fluorescence in situ hybridization and flow cytometry. Nucleic Acids Res. 26:3651-3656(1998) PubMed=9738977; DOI=10.1111/j.1349-7006.1998.tb03275.x Takizawa J., Suzuki R., Kuroda H., Utsunomiya A., Kagami Y., Joh T., Aizawa Y., Ueda R., Seto M. Expression of the TCL1 gene at 14q32 in B-cell malignancies but not in adult T-cell leukemia. Jpn. J. Cancer Res. 89:712-718(1998) PubMed=9787181; DOI=10.1182/blood.V92.9.3410 Sakai A., Thieblemont C., Wellmann A., Jaffe E.S., Raffeld M. PTEN gene alterations in lymphoid neoplasms. Blood 92:3410-3415(1998) PubMed=9933131; DOI=10.1016/S0145-2126(98)00133-7 Burger R., Hansen-Hagge T.E., Drexler H.G., Gramatzki M. Heterogeneity of T-acute lymphoblastic leukemia (T-ALL) cell lines: suggestion for classification by immunophenotype and T-cell receptor studies. Leuk. Res. 23:19-27(1999) PubMed=10071127; DOI=10.1016/S0145-2126(98)00146-5 Kawamura M., Ohnishi H., Guo S.X., Sheng X.-M., Minegishi M., Hanada R., Horibe K., Hongo T., Kaneko Y., Bessho F., Yanagisawa M., Sekiya T., Hayashi Y. Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia. Leuk. Res. 23:115-126(1999) PubMed=10739008; DOI=10.1016/S0145-2126(99)00182-4 Inoue K., Kohno T., Takakura S., Hayashi Y., Mizoguchi H., Yokota J. Frequent microsatellite instability and BAX mutations in T cell acute lymphoblastic leukemia cell lines. Leuk. Res. 24:255-262(2000) PubMed=11021758; DOI=10.1038/sj.leu.2401891 Majka M., Rozmyslowicz T., Honczarenko M., Ratajczak J., Wasik M.A., Gaulton G.N., Ratajczak M.Z. Biological significance of the expression of HIV-related chemokine coreceptors (CCR5 and CXCR4) and their ligands by human hematopoietic cell lines. Leukemia 14:1821-1832(2000) DOI=10.1016/B978-0-12-221970-2.50457-5 Drexler H.G. The leukemia-lymphoma cell line factsbook. (In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001) PubMed=11226526; DOI=10.1016/S0145-2126(00)00121-1 Inoue K., Kohno T., Takakura S., Hayashi Y., Mizoguchi H., Yokota J. Corrigendum to: Frequent microsatellite instability and BAX mutations in T cell acute lymphoblastic leukemia cell lines Leukemia Research 24 (2000),255-262. Leuk. Res. 25:275-278(2001) PubMed=15028022; DOI=10.1111/j.1440-1827.2004.01612.x Kamimura K., Hojo H., Abe M. Characterization of expression of protein kinase C isozymes in human B-cell lymphoma: relationship between its expression and prognosis. Pathol. Int. 54:224-230(2004) PubMed=15472075; DOI=10.1126/science.1102160 Weng A.P., Ferrando A.A., Lee W., Morris J.P. IV, Silverman L.B., Sanchez-Irizarry C., Blacklow S.C., Look A.T., Aster J.C. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306:269-271(2004) PubMed=16408098; DOI=10.1038/sj.leu.2404081 Quentmeier H., MacLeod R.A.F., Zaborski M., Drexler H.G. JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders. Leukemia 20:471-476(2006) PubMed=17117183; DOI=10.1038/sj.bjc.6603447 Beesley A.H., Palmer M.-L., Ford J., Weller R.E., Cummings A.J., Freitas J.R., Firth M.J., Perera K.U., de Klerk N.H., Kees U.R. Authenticity and drug resistance in a panel of acute lymphoblastic leukaemia cell lines. Br. J. Cancer 95:1537-1544(2006) PubMed=17170727; DOI=10.1038/sj.leu.2404486 Sandberg Y., Verhaaf B., van Gastel-Mol E.J., Wolvers-Tettero I.L.M., de Vos J., MacLeod R.A.F., Noordzij J.G., Dik W.A., van Dongen J.J.M., Langerak A.W. Human T-cell lines with well-defined T-cell receptor gene rearrangements as controls for the BIOMED-2 multiplex polymerase chain reaction tubes. Leukemia 21:230-237(2007) PubMed=19220422; DOI=10.1111/j.1600-0609.2009.01211.x Kamihira S., Terada C., Sasaki D., Yanagihara K., Tsukasaki K., Hasegawa H., Yamada Y. Aberrant p53 protein expression and function in a panel of hematopoietic cell lines with different p53 mutations. Eur. J. Haematol. 82:301-307(2009) PubMed=19473701; DOI=10.1016/j.leukres.2009.04.032 Lo T.C.T., Barnhill L.M., Kim Y., Nakae E.A., Yu A.L.-T., Diccianni M.B. Inactivation of SHIP1 in T-cell acute lymphoblastic leukemia due to mutation and extensive alternative splicing. Leuk. Res. 33:1562-1566(2009) PubMed=19608861; DOI=10.1126/science.1175371 Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., Olsen J.V., Mann M. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325:834-840(2009) PubMed=22278370; DOI=10.1074/mcp.M111.014050 Geiger T., Wehner A., Schaab C., Cox J., Mann M. Comparative proteomic analysis of eleven common cell lines reveals ubiquitous but varying expression of most proteins. Mol. Cell. Proteomics 11:M111.014050-M111.014050(2012) PubMed=22460905; DOI=10.1038/nature11003 Barretina J.G., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., Reddy A., Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J., Korejwa A., Jane-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E., Raman P., Shipway A., Engels I.H., Cheng J., Yu G.-Y.K., Yu J.-J., Aspesi P. Jr., de Silva M., Jagtap K., Jones M.D., Wang L., Hatton C., Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C., Liefeld T., MacConaill L.E., Winckler W., Reich M., Li N.-X., Mesirov J.P., Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L., Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M.L., Golub T.R., Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483:603-607(2012) PubMed=22675565; DOI=10.1371/journal.pone.0038463 Atak Z.K., De Keersmaecker K., Gianfelici V., Geerdens E., Vandepoel R., Pauwels D., Porcu M., Lahortiga I., Brys V., Dirks W.G., Quentmeier H., Cloos J., Cuppens H., Uyttebroeck A., Vandenberghe P., Cools J., Aerts S. High accuracy mutation detection in leukemia on a selected panel of cancer genes. PLoS ONE 7:E38463-E38463(2012) PubMed=22944676; DOI=10.1515/hsz-2012-0195 Reinke S.O., Bayer M., Berger M., Hinderlich S., Blanchard V. The analysis of N-glycans of cell membrane proteins from human hematopoietic cell lines reveals distinctions in their pattern. Biol. Chem. 393:731-747(2012) PubMed=23325432; DOI=10.1101/gr.147942.112 Varley K.E., Gertz J., Bowling K.M., Parker S.L., Reddy T.E., Pauli-Behn F., Cross M.K., Williams B.A., Stamatoyannopoulos J.A., Crawford G.E., Absher D.M., Wold B.J., Myers R.M. Dynamic DNA methylation across diverse human cell lines and tissues. Genome Res. 23:555-567(2013) PubMed=24618588; DOI=10.1371/journal.pone.0091433 Chernobrovkin A.L., Zubarev R.A. Detection of viral proteins in human cells lines by xeno-proteomics: elimination of the last valid excuse for not testing every cellular proteome dataset for viral proteins. PLoS ONE 9:E91433-E91433(2014) PubMed=26074081; DOI=10.1016/j.celrep.2015.05.029 Giansanti P., Aye T.T., van den Toorn H., Peng M., van Breukelen B., Heck A.J.R. An augmented multiple-protease-based human phosphopeptide atlas. Cell Rep. 11:1834-1843(2015) PubMed=27397505; DOI=10.1016/j.cell.2016.06.017 Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X.-M., Egan R.K., Liu Q.-S., Mironenko T., Mitropoulos X., Richardson L., Wang J.-H., Zhang T.-H., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J. A landscape of pharmacogenomic interactions in cancer. Cell 166:740-754(2016) PubMed=28357668; DOI=10.1007/978-1-4939-6872-5_11 Raimondi V., Minuzzo S.A., Ciminale V., D'Agostino D.M. STR profiling of HTLV-1-infected cell lines. Methods Mol. Biol. 1582:143-154(2017) PubMed=29967540; DOI=10.1038/s41594-018-0084-y Akimov V., Barrio-Hernandez I., Hansen S.V.F., Hallenborg P., Pedersen A.-K., Bekker-Jensen D.B., Puglia M., Christensen S.D.K., Vanselow J.T., Nielsen M.M., Kratchmarova I., Kelstrup C.D., Olsen J.V., Blagoev B. UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat. Struct. Mol. Biol. 25:631-640(2018) PubMed=30285677; DOI=10.1186/s12885-018-4840-5 Tan K.-T., Ding L.-W., Sun Q.-Y., Lao Z.-T., Chien W., Ren X., Xiao J.-F., Loh X.-Y., Xu L., Lill M., Mayakonda A., Lin D.-C., Yang H., Koeffler H.P. Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines. BMC Cancer 18:940.1-940.13(2018) PubMed=30629668; DOI=10.1371/journal.pone.0210404 Uphoff C.C., Pommerenke C., Denkmann S.A., Drexler H.G. Screening human cell lines for viral infections applying RNA-Seq data analysis. PLoS ONE 14:E0210404-E0210404(2019) PubMed=30844424; DOI=10.1016/j.humimm.2019.03.001 Creary L.E., Guerra S.G., Chong W., Brown C.J., Turner T.R., Robinson J., Bultitude W.P., Mayor N.P., Marsh S.G.E., Saito K., Lam K., Duke J.L., Mosbruger T.L., Ferriola D., Monos D.S., Willis A., Askar M., Fischer G.F., Saw C.L., Ragoussis J., Petrek M., Serra-Pages C., Juan Otero M., Stavropoulos-Giokas C., Dinou A., Ameen R., Al Shemmari S., Spierings E., Gendzekhadze K., Morris G.P., Zhang Q.-H., Kashi Z., Hsu S., Gangavarapu S., Mallempati K.C., Yamamoto F., Osoegawa K., Vayntrub T., Chang C.-J., Hansen J.A., Fernandez-Vina M.A. Next-generation HLA typing of 382 International Histocompatibility Working Group reference B-lymphoblastoid cell lines: report from the 17th International HLA and Immunogenetics Workshop. Hum. Immunol. 80:449-460(2019) PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747 Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A. An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines. Cancer Res. 79:1263-1273(2019) PubMed=31068700; DOI=10.1038/s41586-019-1186-3 Ghandi M., Huang F.W., Jane-Valbuena J., Kryukov G.V., Lo C.C., McDonald E.R. III, Barretina J.G., Gelfand E.T., Bielski C.M., Li H., Hu K., Andreev-Drakhlin A.Y., Kim J., Hess J.M., Haas B.J., Aguet F., Weir B.A., Rothberg M.V., Paolella B.R., Lawrence M.S., Akbani R., Lu Y., Tiv H.L., Gokhale P.C., de Weck A., Mansour A.A., Oh C., Shih J., Hadi K., Rosen Y., Bistline J., Venkatesan K., Reddy A., Sonkin D., Liu M., Lehar J., Korn J.M., Porter D.A., Jones M.D., Golji J., Caponigro G., Taylor J.E., Dunning C.M., Creech A.L., Warren A.C., McFarland J.M., Zamanighomi M., Kauffmann A., Stransky N., Imielinski M., Maruvka Y.E., Cherniack A.D., Tsherniak A., Vazquez F., Jaffe J.D., Lane A.A., Weinstock D.M., Johannessen C.M., Morrissey M.P., Stegmeier F., Schlegel R., Hahn W.C., Getz G., Mills G.B., Boehm J.S., Golub T.R., Garraway L.A., Sellers W.R. Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature 569:503-508(2019) PubMed=31160637; DOI=10.1038/s41598-019-44491-x Quentmeier H., Pommerenke C., Dirks W.G., Eberth S., Koeppel M., MacLeod R.A.F., Nagel S., Steube K., Uphoff C.C., Drexler H.G. The LL-100 panel: 100 cell lines for blood cancer studies. Sci. Rep. 9:8218-8218(2019) PubMed=31978347; DOI=10.1016/j.cell.2019.12.023 Nusinow D.P., Szpyt J., Ghandi M., Rose C.M., McDonald E.R. III, Kalocsay M., Jane-Valbuena J., Gelfand E.T., Schweppe D.K., Jedrychowski M.P., Golji J., Porter D.A., Rejtar T., Wang Y.K., Kryukov G.V., Stegmeier F., Erickson B.K., Garraway L.A., Sellers W.R., Gygi S.P. Quantitative proteomics of the Cancer Cell Line Encyclopedia. Cell 180:387-402.e16(2020) PubMed=35354797; DOI=10.1038/s41467-022-29224-5 Leo I.R., Aswad L., Stahl M., Kunold E., Post F., Erkers T., Struyf N., Mermelekas G., Joshi R.N., Gracia-Villacampa E., Ostling P., Kallioniemi O.-P., Pokrovskaja Tamm K., Siavelis I., Lehtio J., Vesterlund M., Jafari R. Integrative multi-omics and drug response profiling of childhood acute lymphoblastic leukemia cell lines. Nat. Commun. 13:1691.1-1691.19(2022) PubMed=35839778; DOI=10.1016/j.ccell.2022.06.010 Goncalves E., Poulos R.C., Cai Z.-X., Barthorpe S., Manda S.S., Lucas N., Beck A., Bucio-Noble D., Dausmann M., Hall C., Hecker M., Koh J., Lightfoot H., Mahboob S., Mali I., Morris J., Richardson L., Seneviratne A.J., Shepherd R., Sykes E., Thomas F., Valentini S., Williams S.G., Wu Y.-X., Xavier D., MacKenzie K.L., Hains P.G., Tully B., Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R. Pan-cancer proteomic map of 949 human cell lines. Cancer Cell 40:835-849.e8(2022) |